(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 6.09% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.29%.
Elanco Animal Health's revenue in 2026 is $4,715,000,000.On average, 17 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,545,997,722,317, with the lowest ELAN revenue forecast at $2,426,180,215,760, and the highest ELAN revenue forecast at $2,751,825,306,195. On average, 17 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,670,786,909,644, with the lowest ELAN revenue forecast at $2,523,127,990,775, and the highest ELAN revenue forecast at $2,779,169,550,430.
In 2028, ELAN is forecast to generate $2,800,050,609,664 in revenue, with the lowest revenue forecast at $2,623,555,942,329 and the highest revenue forecast at $2,946,715,192,379.